Breast Cancer Recurrence - Death & Vitamin D

Based upon recent clinical research findings, Vitamin Dstudy, breast cancer patients with a significant
is the only remaining vitamin that may have significantdeficiency of Vitamin D were observed to be almost
cancer and cardiovascular disease preventiontwice as likely (71 percent increased risk) to
properties. Recent large-scale prospective randomizedexperience a recurrence of their breast cancer, and
clinical research trials have not only failed to identify athey were 60 percent more likely to die, when
cancer prevention role (beyond a healthy balancedcompared to the patients who had normal levels of
diet) for Vitamin E, Vitamin C, folate, andVitamin D in their blood.
beta-carotene (a member of the Vitamin A family)Although this clinical study included relatively few
supplements, but data from these trials have stronglypatients, it does, nonetheless, raise the possibility that
suggested an increased risk of adverse healtha significant deficiency of Vitamin D may be
outcomes, at least in some sub-groups of patients,associated with a worse prognosis in patients with
with supplements of several of these vitamins.early-stage breast cancer. Another related finding in
Alas, as is typically the case with public health studies,this study was that very low levels of Vitamin D also
the clinical data regarding Vitamin D is not withoutappeared to be associated with breast tumors with
inconsistency, and the data on Vitamin D and cancermore aggressive features when examined under the
incidence has not been uniformly positive, either.microscope, which is consistent with other studies
However, multiple recent epidemiological andthat have suggested a link between "high grade"
prospective clinical research studies have at leastbreast tumors and decreased blood levels of Vitamin
suggested that low levels of Vitamin D in our bodiesD. At the same time, as I have already mentioned,
may, in fact, be associated with a higher risk ofthe available data regarding Vitamin D levels (and the
developing certain cancers (look for a moreuse of Vitamin D supplements) has not been
comprehensive review of the data on Vitamin D andconsistent, and other clinical studies have failed to
cancer prevention in my forthcoming book, "Aidentify a link between Vitamin D and breast cancer
Cancer Prevention Guide for the Human Race").risk. There is also some experimental data available
Moreover, decreased blood levels of Vitamin D alsosuggesting that very high levels of Vitamin D in the
appear to be linked to an increased risk ofblood may also be associated with poorer outcomes
cardiovascular disease as well.in women with breast cancer (similar findings have
Now, a newly published prospective clinical researchalso been reported for excessive Vitamin D levels
trial suggests that decreased levels of Vitamin D inand cardiovascular disease outcomes). Taken
the blood appears to be associated with an increasedtogether, the data from these various studies
risk of breast cancer recurrence, and death due tostrongly suggest that there may be a fairly narrow
breast cancer, in women previously diagnosed with"optimal range" of Vitamin D levels in the blood that
early stage breast cancer. In this study, which hasare associated with a decreased risk of breast
just been published in the Journal of Clinical Oncology,cancer, a decreased risk of breast cancer recurrence
512 women with early-stage breast cancer,(and death), and a decreased risk of cardiovascular
diagnosed between 1989 and 1996, weredisease; and that excessively high or low levels of
prospectively followed for an average of nearly 12this vitamin may have adverse health effects in
years. Blood was routinely collected from all womenthese areas.
following their diagnosis of breast cancer, as a partThe next obvious step is to conduct larger
of this clinical research trial. The women were thenprospective clinical research trials that secretly
closely followed for recurrence of their breast cancer,randomize patient volunteers to receive various
and for death due to breast cancer and otherdoses of Vitamin D, versus placebo (sugar) pills.
causes.There are several such studies already underway (or
As with other similar studies, a surprisingly largeabout to start), involving both cancer patients and
number of these otherwise healthy women werepatients without cancers. However, it will likely take
discovered to have decreased levels of Vitamin D inanother 10 years for mature data to emerge from
their blood. In 38 percent of these women, Vitamin Dthese ongoing studies. Meanwhile, my advice is to eat
levels were significantly below normal levels, whilea healthy and well-balanced diet. If you are a breast
another 39 percent of these women had mildlyor prostate or colorectal cancer survivor, or if you
decreased levels of circulating Vitamin D. Amonghave one or more risk factors for these cancers (or
these 512 women, 116 experienced metastaticfor cardiovascular disease), then you may also want
recurrence of their breast cancer during the courseto ask your physician to measure the level of active
of this prospective clinical study, while 87 womenVitamin D in your blood. If you are significantly
died with evidence of recurrent breast cancer.deficient in Vitamin D, then your physician might
The results of this prospective clinical study wereconsider the possibility of Vitamin D supplementation
rather compelling. The 10-year survival rates forin conjunction with careful serial monitoring of your
these women with early-stage breast cancer variedVitamin D levels.
significantly according to the level of Vitamin D in___
their blood. Survival at 10 years following breastDisclaimer: As always, my advice to readers is to
cancer diagnosis was 74 percent, 85 percent, and 85seek the advice of your physician before making any
percent for women with significantly deficient, mildlysignificant changes in medications, diet, or level of
deficient, and normal Vitamin D levels, respectively.physical activity.
Based upon the analysis of all of the data from this